INCYTE CORP (INCY) Stock Analyst Ratings
NASDAQ:INCY • US45337C1027
100.85 USD
-0.47 (-0.46%)
At close: Feb 23, 2026
100.845 USD
0 (0%)
After Hours: 2/23/2026, 6:45:18 PM
ChartMill assigns a Buy % Consensus number of 75% to INCY. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 104.47. This target is 3.59% above the current price.
- INCY was analyzed by 32 analysts. The buy percentage consensus is at 75. So analysts seem to be have mildly positive about INCY.
- In the previous month the buy percentage consensus was at a similar level.
- INCY was analyzed by 32 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-02-18 | Barclays | Maintains | Overweight -> Overweight |
| 2026-02-11 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2026-02-11 | Stifel | Maintains | Buy -> Buy |
| 2026-02-11 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2026-02-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2026-02-06 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2026-02-05 | HC Wainwright & Co. | Initiate | Buy |
| 2026-02-04 | Barclays | Maintains | Overweight -> Overweight |
| 2026-01-20 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2026-01-13 | TD Cowen | Maintains | Buy -> Buy |
| 2026-01-06 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-12-08 | Mizuho | Upgrade | Neutral -> Outperform |
| 2025-12-08 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-12-08 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-11-24 | Barclays | Maintains | Overweight -> Overweight |
| 2025-11-04 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-11-03 | Guggenheim | Upgrade | Neutral -> Buy |
| 2025-10-29 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-10-29 | Barclays | Maintains | Overweight -> Overweight |
| 2025-10-29 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-10-29 | Truist Securities | Reiterate | Hold -> Hold |
| 2025-10-09 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-09-24 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-09-22 | Stifel | Maintains | Buy -> Buy |
| 2025-09-19 | Guggenheim | Reiterate | Neutral -> Neutral |
| 2025-09-04 | B of A Securities | Maintains | Buy -> Buy |
| 2025-08-22 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-08-06 | Wells Fargo | Upgrade | Equal-Weight -> Overweight |
| 2025-08-01 | Barclays | Initiate | Overweight |
| 2025-07-30 | BMO Capital | Maintains | Underperform -> Underperform |
INCYTE CORP / INCY FAQ
Can you provide the average price target for INCYTE CORP stock?
32 analysts have analysed INCY and the average price target is 104.47 USD. This implies a price increase of 3.59% is expected in the next year compared to the current price of 100.85.
What is the consensus rating for INCYTE CORP (INCY) stock?
The consensus rating for INCYTE CORP (INCY) is 75 / 100 . This indicates that analysts generally have a positive outlook on the stock.